התחייבויות לטווח ארוך להון עצמי: Applied Therapeutics Inc. (APLT)

Applied Therapeutics brings together leading biochemists to develop proprietary drugs, ensuring monopoly status upon market entry. The long-term debt-to-equity ratio demonstrates the risk distribution between shareholders and creditors, where 0.00 determines the current status of the parameter. The issuer's financial stability relies exclusively on external financing and clinical trial results.

This indicator assesses the proportion of long-term liabilities within the equity structure to determine the company's degree of financial leverage. For Applied Therapeutics (APLT), with its stable demand for rare disease therapies, low leverage minimizes debt service risks. By analyzing the long-term debt-to-equity ratio, an investor can discern the actual resilience of the balance sheet. This trend reflects management's caution regarding the acquisition of borrowed funds, which guarantees high business solvency across all market cycles.